| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1669 | 2019 |
| Meta‐analysis of early nonmotor features and risk factors for Parkinson disease AJ Noyce, JP Bestwick, L Silveira‐Moriyama, CH Hawkes, G Giovannoni, ... Annals of neurology 72 (6), 893-901, 2012 | 1070 | 2012 |
| Prediagnostic presentations of Parkinson's disease in primary care: a case-control study A Schrag, L Horsfall, K Walters, A Noyce, I Petersen The Lancet Neurology 14 (1), 57-64, 2015 | 743 | 2015 |
| Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R Von Coelln, ... Movement Disorders 34 (6), 866-875, 2019 | 300 | 2019 |
| Constipation preceding Parkinson's disease: a systematic review and meta-analysis KL Adams-Carr, JP Bestwick, S Shribman, A Lees, A Schrag, AJ Noyce Journal of Neurology, Neurosurgery & Psychiatry 87 (7), 710-716, 2016 | 228 | 2016 |
| Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study E De Pablo-Fernandez, R Goldacre, J Pakpoor, AJ Noyce, TT Warner Neurology 91 (2), e139-e142, 2018 | 227 | 2018 |
| Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study MA Nalls, CY McLean, J Rick, S Eberly, SJ Hutten, K Gwinn, M Sutherland, ... The Lancet Neurology 14 (10), 1002-1009, 2015 | 220 | 2015 |
| Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ... Brain 137 (9), 2480-2492, 2014 | 213 | 2014 |
| The prediagnostic phase of Parkinson's disease AJ Noyce, AJ Lees, AE Schrag Journal of Neurology, Neurosurgery & Psychiatry 87 (8), 871-878, 2016 | 198 | 2016 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 192 | 2020 |
| Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study AJ Noyce, DA Kia, G Hemani, A Nicolas, TR Price, E De Pablo-Fernandez, ... PLoS medicine 14 (6), e1002314, 2017 | 169 | 2017 |
| Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis S Bandres‐Ciga, AJ Noyce, G Hemani, A Nicolas, A Calvo, G Mora, ... Annals of neurology 85 (4), 470-481, 2019 | 167 | 2019 |
| Bone health in Parkinson's disease: a systematic review and meta-analysis KM Torsney, AJ Noyce, KM Doherty, JP Bestwick, R Dobson, AJ Lees Journal of Neurology, Neurosurgery & Psychiatry 85 (10), 1159-1166, 2014 | 159 | 2014 |
| Stiff person syndrome S Hadavi, AJ Noyce, RD Leslie, G Giovannoni Practical neurology 11 (5), 272-282, 2011 | 158 | 2011 |
| The association between type 2 diabetes mellitus and Parkinson’s disease JLY Cheong, E de Pablo-Fernandez, T Foltynie, AJ Noyce Journal of Parkinson's disease 10 (3), 775-789, 2020 | 147 | 2020 |
| Type 2 diabetes as a determinant of Parkinson's disease risk and progression H Chohan, K Senkevich, RK Patel, JP Bestwick, BM Jacobs, ... Movement disorders 36 (6), 1420-1429, 2021 | 144 | 2021 |
| Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts H Iwaki, C Blauwendraat, HL Leonard, G Liu, J Maple-Grødem, JC Corvol, ... Neurology: Genetics 5 (4), e348, 2019 | 142 | 2019 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 131 | 2021 |
| Challenges of modifying disease progression in prediagnostic Parkinson's disease D Salat, AJ Noyce, A Schrag, E Tolosa The Lancet Neurology 15 (6), 637-648, 2016 | 129 | 2016 |
| Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts H Iwaki, C Blauwendraat, HL Leonard, JJ Kim, G Liu, J Maple‐Grødem, ... Movement Disorders 34 (12), 1839-1850, 2019 | 119 | 2019 |
Anette SchragUniversity College LondonVerified email at doctors.org.uk
